Amarin Corp. Plc (AMRN)
15.63
-0.09
(-0.59%)
USD |
NASDAQ |
Feb 20, 16:00
15.59
-0.04
(-0.24%)
After-Hours: 20:00
Amarin EPS Diluted (Quarterly) : -0.3701 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Trinity Biotech Plc | -0.274 |
| Alkermes Plc | 0.4911 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Biodexa Pharmaceuticals Plc | -- |
| Evaxion AS | -0.2862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.690M |
| Revenue (Quarterly) | 49.36M |
| Total Expenses (Quarterly) | 57.05M |
| Enterprise Value | 44.79M |
| Gross Profit Margin (Quarterly) | 42.97% |
| Profit Margin (Quarterly) | -15.58% |
| Earnings Yield | -26.65% |
| Normalized Earnings Yield | -19.66 |